Civica Rx picked Xellia Pharmaceuticals to make antibiotics for the hospitals in Civica’s network

A group of 800 hospitals created a nonprofit generic drugmaker called Civica Rx, just revealed the first two treatments they plan to make. The organization picked a supplier, Xellia Pharmaceuticals based in Copenhagen, and two antibiotics, vancomycin and daptomycin, to start with in its plan to upend the generic pharma business. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.